|
⚲
|
| Keyboard |
| Freeman Jonathan E
✚
|
|
|---|---|
| CIK # | 0001708133 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001708133] | |
| 4 | [0001708133] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Freeman Jonathan E | |
| RXi Pharmaceuticals Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
RXi Pharmaceuticals Corp PHIO
Common Stock, $.0001 par value
|
2026-02-05 | Grant | 16,600 | $0.00 | |
|
RXi Pharmaceuticals Corp PHIO
Common Stock, $0.0001 par value
|
2024-09-11 | Grant | 1,000 | $0.00 | |
|
RXi Pharmaceuticals Corp PHIO
Common stock, $0.0001 par value
|
2023-02-17 | Grant | 1,500 | $0.00 | |
|
RXi Pharmaceuticals Corp PHIO
Common stock, $0.0001 par value
|
2022-02-15 | Grant | 10,000 | $0.00 | |
|
RXi Pharmaceuticals Corp PHIO
Common stock, $0.0001 par value
|
2021-03-01 | Grant | 10,000 | $0.00 | |
|
RXi Pharmaceuticals Corp PHIO
Common stock
|
2019-02-13 | Grant | 10,000 | $0.00 | |
|
RXi Pharmaceuticals Corp RXII
Common Stock
|
2018-08-01 | Grant | 10,000 | $0.00 | |
|
RXi Pharmaceuticals Corp RXII
Stock option (right to buy) · derivative
|
2017-06-06 | Grant | 3,500 | $0.00 |